AKBA News and Press, Akebia Therapeutics Inc. From 10/18/23

Akebia Therapeutics Announces Five Poster Presentations at ASN Kidney Week 2023 PR Newswire CAMBRIDGE, Mass. , Oct. 18, 2023 /PRNewswire/ -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better t...

2023-09-28 08:51:12 ET More on Akebia Akebia Therapeutics, Inc. (AKBA) Q2 2023 Earnings Call Transcript Akebia: 'Hold' Through Regulatory And Financial Hurdles Akebia Therapeutics: Take Profits Before Second Quarter Report Akebia gains as Australia clears kid...

Akebia Therapeutics Resubmits New Drug Application to the FDA for Vadadustat PR Newswire CAMBRIDGE, Mass. , Sept. 28, 2023 /PRNewswire/ -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the...

2023-09-26 13:13:48 ET More on Akebia Seeking Alpha’s Quant Rating on Akebia Akebia Therapeutics, Inc. (AKBA) Q2 2023 Earnings Call Transcript Akebia: 'Hold' Through Regulatory And Financial Hurdles Akebia Therapeutics: Take Profits Before Second Quart...

Akebia Announces Approval of Vafseo® (vadadustat) in Australia and Provides Commercial Update PR Newswire CAMBRIDGE, Mass. , Sept. 26, 2023 /PRNewswire/ -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA) today announced that Australia's ...

2023-08-28 15:12:12 ET If you’re looking to gain an edge in the stock market today, you’ve got to have more than a list of penny stocks to watch. You need to understand how to use the wild volatility that has been created this year to your advantage. Whether there’s...

2023-08-28 10:05:32 ET More on Health Care Select Sector SPDR Stagflation Playbook: Short Tech (QQQ/ARKK) And Long Healthcare ( XLV ) Tech Ruled The First Half Of 2023, The Industry You Need To Watch In The Second Half XLV Vs. VHT: A Head-To-Head Healthcare ETF C...

2023-08-28 10:04:12 ET More on Akebia Akebia Therapeutics, Inc. ( AKBA ) Q2 2023 Earnings Call Transcript Akebia: 'Hold' Through Regulatory And Financial Hurdles Akebia Therapeutics: Take Profits Before Second Quarter Report Akebia GAAP EPS of -$0.06 miss...

2023-08-28 08:43:42 ET Hersha Hospitality ( HT ) +57% trust agrees to $1.4B buyout by KSL. LQR House ( LQR ) +40% . GD Culture Group  ( GDC ) +26% Group Limited Expands Grids of the Future Portfolio with TikTok to Drive Growth of Live-Streaming E-Com...

Akebia Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights PR Newswire Akebia to host conference call on August 25, 2023 at 9:00 a.m. ET Expects to resubmit NDA for vadadustat as a treatment for anemia due to CKD in adult p...